Status:
COMPLETED
The Effect of Early Mobilization in Mild to Moderate Hemorrhagic Stroke
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hemorrhagic Stroke
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
This study aims to examine the outcomes of early mobilization and early intervention within 24-72 hours after the onset of hemorrhagic stroke in patients admitted to an intensive care unit within 24 h...
Detailed Description
Early intervention has been proven to enhance post-stroke functional recovery. Recent studies have proposed that early mobilization (out-of-bed activities) also contributes to an individual's function...
Eligibility Criteria
Inclusion
- The inclusion criteria will be as follows:
- patients with a first time intracerebral (either cortical or subcortical) hemorrhage with unilateral hemiparesis/ hemiplegia confirmed by magnetic resonance imaging or computed tomography;
- patients with no contraindications to being mobilized (early intervention) within 24 hours of stroke onset (based on the medical team's clinical judgment: including systolic blood pressure (SBP)\<160mmHg in resting; resting heart rate (HR)\<130 bpm; no hydrocephalus; 80\< mean arterial pressure (MAP)\<110 mmHg before intervention);
- patients with National Institutes of Health Stroke Scale (NIHSS) scores at admission ranging from 1 to 20;
- patients with total activity of living independence pre-stroke; and
- patients between 20 and 80 years old.
- The exclusion criteria will be as follows:
- patients with mild to moderate deficits as described above (3);
- patients who are unable to complete the baseline survey because of serious aphasia, language difficulties, or cognitive deficits;
- patients with other medical conditions, such as severe heart failure, acute coronary syndrome, or lower-limb disorders, that prevent early mobilization; and
- patients who are unable to provide informed consent. In addition, we will exclude those showing rapid early deterioration of symptoms, as well as those with a concurrent diagnosis of rapidly deteriorating disease (e.g., terminal cancer).
Exclusion
Key Trial Info
Start Date :
September 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03292211
Start Date
September 12 2017
End Date
February 10 2019
Last Update
April 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100